Structural and biological exploration of Phe3-Phe 4-modified endomorphin-2 peptidomimetics

Giordano Lesma, Severo Salvadori, Francesco Airaghi, Thomas F. Murray, Teresa Recca, Alessandro Sacchetti, Gianfranco Balboni, Alessandra Silvani

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

This study reports on our ongoing investigation on hybrid EM-2 analogues, in which the great potential of β-amino acids was exploited to generate multiple conformational modifications at the key positions 3 and 4 of the parent peptide. The effect on the opioid binding affinity was evaluated, by means of ligand stimulated binding assays, which indicated a high nanomolar affinity toward the μ-receptor, with appreciable μ/δ selectivity, for some of the new compounds. The three-dimensional properties of the high affinity μ opioid receptor (MOR) ligands were investigated by proton nuclear magnetic resonance, molecular dynamics, and docking studies. In solution, the structures showed extended conformations, which are in agreement with the commonly accepted pharmacophore model for EM-2. From docking studies on an active form of the MOR model, different ligand-receptor interactions have been identified, thus confirming the ability of active compounds to assume a biologically active conformation.

Original languageEnglish
Pages (from-to)795-799
Number of pages5
JournalACS Medicinal Chemistry Letters
Volume4
Issue number8
DOIs
StatePublished - Aug 8 2013

Fingerprint

Peptidomimetics
Ligands
Conformations
Nuclear magnetic resonance
Opioid Receptors
Molecular Dynamics Simulation
Opioid Analgesics
Molecular dynamics
Protons
Assays
Magnetic Resonance Spectroscopy
Amino Acids
Peptides
endomorphin 2

All Science Journal Classification (ASJC) codes

  • Organic Chemistry
  • Drug Discovery
  • Biochemistry

Cite this

Structural and biological exploration of Phe3-Phe 4-modified endomorphin-2 peptidomimetics. / Lesma, Giordano; Salvadori, Severo; Airaghi, Francesco; Murray, Thomas F.; Recca, Teresa; Sacchetti, Alessandro; Balboni, Gianfranco; Silvani, Alessandra.

In: ACS Medicinal Chemistry Letters, Vol. 4, No. 8, 08.08.2013, p. 795-799.

Research output: Contribution to journalArticle

Lesma, G, Salvadori, S, Airaghi, F, Murray, TF, Recca, T, Sacchetti, A, Balboni, G & Silvani, A 2013, 'Structural and biological exploration of Phe3-Phe 4-modified endomorphin-2 peptidomimetics', ACS Medicinal Chemistry Letters, vol. 4, no. 8, pp. 795-799. https://doi.org/10.1021/ml400189r
Lesma, Giordano ; Salvadori, Severo ; Airaghi, Francesco ; Murray, Thomas F. ; Recca, Teresa ; Sacchetti, Alessandro ; Balboni, Gianfranco ; Silvani, Alessandra. / Structural and biological exploration of Phe3-Phe 4-modified endomorphin-2 peptidomimetics. In: ACS Medicinal Chemistry Letters. 2013 ; Vol. 4, No. 8. pp. 795-799.
@article{e619aaa87919429eb7ec7459a5b4a608,
title = "Structural and biological exploration of Phe3-Phe 4-modified endomorphin-2 peptidomimetics",
abstract = "This study reports on our ongoing investigation on hybrid EM-2 analogues, in which the great potential of β-amino acids was exploited to generate multiple conformational modifications at the key positions 3 and 4 of the parent peptide. The effect on the opioid binding affinity was evaluated, by means of ligand stimulated binding assays, which indicated a high nanomolar affinity toward the μ-receptor, with appreciable μ/δ selectivity, for some of the new compounds. The three-dimensional properties of the high affinity μ opioid receptor (MOR) ligands were investigated by proton nuclear magnetic resonance, molecular dynamics, and docking studies. In solution, the structures showed extended conformations, which are in agreement with the commonly accepted pharmacophore model for EM-2. From docking studies on an active form of the MOR model, different ligand-receptor interactions have been identified, thus confirming the ability of active compounds to assume a biologically active conformation.",
author = "Giordano Lesma and Severo Salvadori and Francesco Airaghi and Murray, {Thomas F.} and Teresa Recca and Alessandro Sacchetti and Gianfranco Balboni and Alessandra Silvani",
year = "2013",
month = "8",
day = "8",
doi = "10.1021/ml400189r",
language = "English",
volume = "4",
pages = "795--799",
journal = "ACS Medicinal Chemistry Letters",
issn = "1948-5875",
publisher = "American Chemical Society",
number = "8",

}

TY - JOUR

T1 - Structural and biological exploration of Phe3-Phe 4-modified endomorphin-2 peptidomimetics

AU - Lesma, Giordano

AU - Salvadori, Severo

AU - Airaghi, Francesco

AU - Murray, Thomas F.

AU - Recca, Teresa

AU - Sacchetti, Alessandro

AU - Balboni, Gianfranco

AU - Silvani, Alessandra

PY - 2013/8/8

Y1 - 2013/8/8

N2 - This study reports on our ongoing investigation on hybrid EM-2 analogues, in which the great potential of β-amino acids was exploited to generate multiple conformational modifications at the key positions 3 and 4 of the parent peptide. The effect on the opioid binding affinity was evaluated, by means of ligand stimulated binding assays, which indicated a high nanomolar affinity toward the μ-receptor, with appreciable μ/δ selectivity, for some of the new compounds. The three-dimensional properties of the high affinity μ opioid receptor (MOR) ligands were investigated by proton nuclear magnetic resonance, molecular dynamics, and docking studies. In solution, the structures showed extended conformations, which are in agreement with the commonly accepted pharmacophore model for EM-2. From docking studies on an active form of the MOR model, different ligand-receptor interactions have been identified, thus confirming the ability of active compounds to assume a biologically active conformation.

AB - This study reports on our ongoing investigation on hybrid EM-2 analogues, in which the great potential of β-amino acids was exploited to generate multiple conformational modifications at the key positions 3 and 4 of the parent peptide. The effect on the opioid binding affinity was evaluated, by means of ligand stimulated binding assays, which indicated a high nanomolar affinity toward the μ-receptor, with appreciable μ/δ selectivity, for some of the new compounds. The three-dimensional properties of the high affinity μ opioid receptor (MOR) ligands were investigated by proton nuclear magnetic resonance, molecular dynamics, and docking studies. In solution, the structures showed extended conformations, which are in agreement with the commonly accepted pharmacophore model for EM-2. From docking studies on an active form of the MOR model, different ligand-receptor interactions have been identified, thus confirming the ability of active compounds to assume a biologically active conformation.

UR - http://www.scopus.com/inward/record.url?scp=84881435753&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84881435753&partnerID=8YFLogxK

U2 - 10.1021/ml400189r

DO - 10.1021/ml400189r

M3 - Article

VL - 4

SP - 795

EP - 799

JO - ACS Medicinal Chemistry Letters

JF - ACS Medicinal Chemistry Letters

SN - 1948-5875

IS - 8

ER -